CN115583898A - A kind of preparation method of aryl isothiocyanate - Google Patents
A kind of preparation method of aryl isothiocyanate Download PDFInfo
- Publication number
- CN115583898A CN115583898A CN202210791874.8A CN202210791874A CN115583898A CN 115583898 A CN115583898 A CN 115583898A CN 202210791874 A CN202210791874 A CN 202210791874A CN 115583898 A CN115583898 A CN 115583898A
- Authority
- CN
- China
- Prior art keywords
- compound
- solvent
- reaction
- formula
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 aryl isothiocyanate Chemical class 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 63
- 238000006243 chemical reaction Methods 0.000 claims abstract description 60
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 32
- 238000007333 cyanation reaction Methods 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 61
- 150000001875 compounds Chemical class 0.000 claims description 60
- 229940125758 compound 15 Drugs 0.000 claims description 55
- 239000002904 solvent Substances 0.000 claims description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 23
- 229940125797 compound 12 Drugs 0.000 claims description 23
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 21
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Substances BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 20
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 claims description 18
- 239000012074 organic phase Substances 0.000 claims description 18
- 239000003960 organic solvent Substances 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 11
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 11
- 125000006239 protecting group Chemical group 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims description 9
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims description 9
- 150000007530 organic bases Chemical class 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 8
- 230000031709 bromination Effects 0.000 claims description 8
- 238000005893 bromination reaction Methods 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- 238000010009 beating Methods 0.000 claims description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical group [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 6
- 239000010410 layer Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 5
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 5
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- 150000008280 chlorinated hydrocarbons Chemical group 0.000 claims description 4
- 150000003950 cyclic amides Chemical class 0.000 claims description 4
- 239000003495 polar organic solvent Substances 0.000 claims description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 150000002825 nitriles Chemical class 0.000 claims description 3
- 239000012044 organic layer Substances 0.000 claims description 3
- 238000012805 post-processing Methods 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- SVJQCVOKYJWUBC-OWOJBTEDSA-N (e)-3-(2,3,4,5-tetrabromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC(Br)=C(Br)C(Br)=C1Br SVJQCVOKYJWUBC-OWOJBTEDSA-N 0.000 claims description 2
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 claims description 2
- 101000835622 Homo sapiens Tubulin-specific chaperone A Proteins 0.000 claims description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- 102100026477 Tubulin-specific chaperone A Human genes 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- SXTGAOTXVOMSFW-UHFFFAOYSA-L magnesium;dithiocyanate Chemical compound [Mg+2].[S-]C#N.[S-]C#N SXTGAOTXVOMSFW-UHFFFAOYSA-L 0.000 claims description 2
- FRYUOUHISNWFTE-UHFFFAOYSA-L manganese(2+);dithiocyanate Chemical compound [Mn+2].[S-]C#N.[S-]C#N FRYUOUHISNWFTE-UHFFFAOYSA-L 0.000 claims description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 claims description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 claims description 2
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 claims description 2
- 229940116357 potassium thiocyanate Drugs 0.000 claims description 2
- 239000003223 protective agent Substances 0.000 claims description 2
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 claims description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 claims description 2
- 150000003462 sulfoxides Chemical class 0.000 claims description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 claims description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 14
- 125000005336 allyloxy group Chemical group 0.000 claims 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 abstract description 12
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 150000001499 aryl bromides Chemical class 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 41
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 7
- KCBJGVDOSBKVKP-UHFFFAOYSA-N 4-[4,4-dimethyl-3-[6-[3-(1,3-oxazol-2-yl)propyl]pyridin-3-yl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-3-fluoro-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(C)(C)N(C=2C=NC(CCCC=3OC=CN=3)=CC=2)C(=S)N1C1=CC=C(C#N)C(C(F)(F)F)=C1F KCBJGVDOSBKVKP-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940125286 pruxelutamide Drugs 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- PHWISQNXPLXQRU-UHFFFAOYSA-N n,n-dimethylcarbamothioyl chloride Chemical compound CN(C)C(Cl)=S PHWISQNXPLXQRU-UHFFFAOYSA-N 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- HBEFYGYBMKPNSZ-UHFFFAOYSA-N s-phenyl chloromethanethioate Chemical compound ClC(=O)SC1=CC=CC=C1 HBEFYGYBMKPNSZ-UHFFFAOYSA-N 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- MARXMDRWROUXMD-UHFFFAOYSA-N 2-bromoisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Br)C(=O)C2=C1 MARXMDRWROUXMD-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HJBWBFZLDZWPHF-UHFFFAOYSA-N apalutamide Chemical compound C1=C(F)C(C(=O)NC)=CC=C1N1C2(CCC2)C(=O)N(C=2C=C(C(C#N)=NC=2)C(F)(F)F)C1=S HJBWBFZLDZWPHF-UHFFFAOYSA-N 0.000 description 2
- 229950007511 apalutamide Drugs 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- WXCXUHSOUPDCQV-UHFFFAOYSA-N enzalutamide Chemical compound C1=C(F)C(C(=O)NC)=CC=C1N1C(C)(C)C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C1=S WXCXUHSOUPDCQV-UHFFFAOYSA-N 0.000 description 2
- 229960004671 enzalutamide Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000002514 liquid chromatography mass spectrum Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 description 1
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical group O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 1
- ZLDMZIXUGCGKMB-UHFFFAOYSA-N 3,5-dibromobenzaldehyde Chemical compound BrC1=CC(Br)=CC(C=O)=C1 ZLDMZIXUGCGKMB-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 229940123407 Androgen receptor antagonist Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical group OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005103 alkyl silyl group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000003936 androgen receptor antagonist Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000010953 base metal Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000008282 halocarbons Chemical group 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- OVSARSKQWCLSJT-UHFFFAOYSA-N n,n-di(propan-2-yl)aniline Chemical compound CC(C)N(C(C)C)C1=CC=CC=C1 OVSARSKQWCLSJT-UHFFFAOYSA-N 0.000 description 1
- SVEUVITYHIHZQE-UHFFFAOYSA-N n-methylpyridin-2-amine Chemical compound CNC1=CC=CC=N1 SVEUVITYHIHZQE-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- JMTCDHVHZSGGJA-UHFFFAOYSA-M potassium hydrogenoxalate Chemical compound [K+].OC(=O)C([O-])=O JMTCDHVHZSGGJA-UHFFFAOYSA-M 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- UJRAXLUXHBUNDO-UHFFFAOYSA-M sodium;hydron;oxalate Chemical compound [Na+].OC(=O)C([O-])=O UJRAXLUXHBUNDO-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- ZKWDCFPLNQTHSH-UHFFFAOYSA-N tribromoisocyanuric acid Chemical compound BrN1C(=O)N(Br)C(=O)N(Br)C1=O ZKWDCFPLNQTHSH-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/14—Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
- C07C209/74—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by halogenation, hydrohalogenation, dehalogenation, or dehydrohalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于医药化工技术领域,具体涉及一种异硫氰酸芳基酯的制备方法。The invention belongs to the technical field of medicine and chemical industry, and in particular relates to a preparation method of aryl isothiocyanate.
背景技术Background technique
异硫氰酸芳基酯是一类重要的医药中间体,广泛用于制备硫代乙内酰脲类结构的雄激素受体拮抗剂,如恩杂鲁胺(Enzalutamide)、阿帕他胺(Apalutamide)和普克鲁胺(Pruxelutamide)。Aryl isothiocyanate is a class of important pharmaceutical intermediates, widely used in the preparation of androgen receptor antagonists of thiohydantoin structure, such as enzalutamide (Enzalutamide), apalutamide ( Apalutamide) and Pruxelutamide.
式A化合物为制备普克鲁胺(Pruxelutamide)的中间体,申请人在CN103608333B中公开了其制备方法,合成路线如下:The compound of formula A is an intermediate for preparing Pruxelutamide, and the applicant has disclosed its preparation method in CN103608333B, and the synthetic route is as follows:
反应路线中以化合物11为原料,经过多步骤反应生成式A化合物。在制备化合物15时,必须采用乙酰基对相应氨基进行保护,然后进行氰基化,脱保护。最后,化合物15与硫光气反应生成目标产物。In the reaction scheme, compound 11 is used as a raw material to generate the compound of formula A through multi-step reactions. When preparing compound 15, the corresponding amino group must be protected with acetyl group, followed by cyanation and deprotection. Finally, compound 15 reacted with thiophosgene to generate the target product.
上述路线存在以下缺陷:1)反应过程中需要对氨基进行保护和脱保护,反应步骤冗长,导致总收率较低(说明书[0483]-[0493]段中记载的化合物11通过溴代、氨基保护、氰基化、脱保护四步反应得到化合物15的总收率为75%×85%×80%×90%=45.9%),且原子经济性差;2)硫光气对环境不友好,不利于生产放大。The above route has the following defects: 1) the amino group needs to be protected and deprotected during the reaction, and the reaction steps are tedious, resulting in a lower overall yield (compound 11 recorded in the section [0483]-[0493] of the description is passed through bromination, amino The total yield of compound 15 obtained by the four-step reaction of protection, cyanation and deprotection is 75%×85%×80%×90%=45.9%), and the atom economy is poor; 2) Thiophosgene is not friendly to the environment, Not conducive to production scale-up.
临床实验结果表明,普克鲁胺(Pruxelutamide)可用于治疗COVID-19,所以目前需要克服现有技术中的缺陷,提供一条适合工业化生产的路线,以制备普克鲁胺的中间体异硫氰酸芳基酯化合物,即式A化合物。The results of clinical trials show that proxalutamide (Pruxelutamide) can be used to treat COVID-19, so it is necessary to overcome the defects in the prior art and provide a route suitable for industrial production to prepare the intermediate isothiocyanate of proxalutamide Acid aryl ester compound, namely formula A compound.
发明内容Contents of the invention
发明要解决的问题The problem to be solved by the invention
为了解决现有技术中的问题,本发明提供了一种制备异硫氰酸芳基酯的方法,本发明采用一步法进行氰基化反应,无需对氨基进行保护;且在反应过程中提出了革除硫光气制备异硫氰酸芳基酯的技术方案,环境更为友好。In order to solve the problems in the prior art, the present invention provides a kind of method for preparing aryl isothiocyanate, the present invention adopts one-step method to carry out cyanation reaction, does not need to protect amino group; And proposed in the reaction process Eliminate the technical scheme of preparing aryl isothiocyanate from thiophosgene, and the environment is more friendly.
用于解决问题的方案solutions to problems
根据本发明的第一个方面,本发明提供了一种制备化合物15的方法,所述方法包括化合物12在溶剂和氰基化试剂的存在下反应生成化合物15,反应方程式如下:According to the first aspect of the present invention, the present invention provides a method for preparing compound 15, said method comprising the reaction of compound 12 to generate compound 15 in the presence of a solvent and a cyanation reagent, the reaction equation is as follows:
优选地,所述溶剂为极性有机溶剂;所述极性有机溶剂选自腈类、亚砜类、链状酰胺类或环状酰胺类中任意一种或多种的组合,优选为N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲基亚砜、乙腈或N-甲基吡咯烷酮中任意一种或多种的组合,进一步优选为N,N-二甲基甲酰胺。Preferably, the solvent is a polar organic solvent; the polar organic solvent is selected from any one or more combinations of nitriles, sulfoxides, chain amides or cyclic amides, preferably N, A combination of any one or more of N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, acetonitrile or N-methylpyrrolidone, more preferably N,N-dimethyl base formamide.
优选地,所述氰基化试剂选自KCN、NaCN、CuCN、Zn(CN)2、Ni(CN)2、K4[Fe(CN)6]或K3[Fe(CN)6]中任意一种,进一步优选为CuCN。Preferably, the cyanation agent is selected from any of KCN, NaCN, CuCN, Zn(CN) 2 , Ni(CN) 2 , K 4 [Fe(CN) 6 ] or K 3 [Fe(CN) 6 ] One, more preferably CuCN.
优选地,所述溶剂为N,N-二甲基甲酰胺,所述氰基化试剂为CuCN。Preferably, the solvent is N,N-dimethylformamide, and the cyanation agent is CuCN.
优选地,所述方法包括将化合物12滴加到溶剂(优选N,N-二甲基甲酰胺)和氰基化试剂(优选CuCN)的体系中,滴加结束后升温反应。Preferably, the method includes adding compound 12 dropwise into a system of a solvent (preferably N,N-dimethylformamide) and a cyanation agent (preferably CuCN), and heating up the reaction after the dropwise addition.
优选地,滴加过程中控制体系温度;更优选地,所述体系温度为10-50℃,优选为10-40℃或15-35℃,进一步优选20-30℃。Preferably, the system temperature is controlled during the dropping process; more preferably, the system temperature is 10-50°C, preferably 10-40°C or 15-35°C, further preferably 20-30°C.
优选地,所述氰基化试剂的摩尔量为化合物12的1.0-1.5倍,优选1.1、1.2、1.3或1.4倍,进一步优选1.1倍。Preferably, the molar amount of the cyanation reagent is 1.0-1.5 times that of compound 12, preferably 1.1, 1.2, 1.3 or 1.4 times, more preferably 1.1 times.
优选地,所述反应的温度为110-140℃,优选110-130℃,进一步优选120-130℃。Preferably, the reaction temperature is 110-140°C, preferably 110-130°C, more preferably 120-130°C.
优选地,所述方法还包括后处理的步骤,所述后处理的步骤包括:向反应体系中加入有机相溶剂和水相溶剂,萃取,洗涤,浓缩有机相,即得。优选地,所述有机相溶剂为氯代烃,优选二氯甲烷;所述水相溶剂为水。Preferably, the method further includes a post-treatment step, and the post-treatment step includes: adding an organic phase solvent and an aqueous phase solvent to the reaction system, extracting, washing, and concentrating the organic phase to obtain the product. Preferably, the organic phase solvent is chlorinated hydrocarbon, preferably dichloromethane; the aqueous phase solvent is water.
优选地,所述后处理的步骤包括:向反应体系中加入有机相溶剂和水相溶剂,萃取,洗涤,浓缩有机相,打浆,即得。优选地,所述有机相溶剂为氯代烃,优选二氯甲烷;所述水相溶剂为氨水;所述打浆采用烷烃来完成,优选正庚烷。Preferably, the post-processing step includes: adding an organic phase solvent and an aqueous phase solvent to the reaction system, extracting, washing, concentrating the organic phase, and beating to obtain the product. Preferably, the organic phase solvent is a chlorinated hydrocarbon, preferably dichloromethane; the aqueous phase solvent is ammonia water; and the beating is done using alkanes, preferably n-heptane.
通过调整该步反应中的加料顺序、加料方式、滴加温度和反应温度等参数,由化合物12通过一步反应即可得到化合物15,且使得该步反应的收率大大提高。并且,发明人优化了后处理步骤,采用加入氨水萃取和打浆工艺,在保证高收率的前提下,使得产物的纯度也得到很大提高。Compound 15 can be obtained from compound 12 through one-step reaction by adjusting the order of addition, method of addition, dropwise addition temperature, and reaction temperature in this step reaction, and the yield of this step reaction is greatly improved. Moreover, the inventor optimized the post-processing steps, and adopted the extraction and beating process by adding ammonia water, so that the purity of the product was also greatly improved under the premise of ensuring a high yield.
进一步地,所述制备化合物15的方法中,化合物12的制备方法包括:化合物11在有机溶剂和溴化试剂的存在下反应生成化合物12,反应方程式如下:Further, in the method for preparing compound 15, the preparation method of compound 12 comprises: reacting compound 11 in the presence of an organic solvent and a brominating reagent to generate compound 12, and the reaction equation is as follows:
优选地,所述有机溶剂为链状或环状酰胺类中任意一种或多种的组合,优选N,N-二甲基甲酰胺或N,N-二甲基乙酰胺中的一种或两种的组合,更优选N,N-二甲基甲酰胺。Preferably, the organic solvent is any one or a combination of chain or cyclic amides, preferably one or more of N,N-dimethylformamide or N,N-dimethylacetamide A combination of the two, more preferably N,N-dimethylformamide.
优选地,所述溴化试剂为N-溴代丁二酰亚胺(NBS)、1,3-二溴-5,5-二甲基海因(DBH)、3,5-二溴苯甲醛(DBBA)、N-溴代邻苯二甲酰亚胺(NBP)或1,3,5-三溴-1,3,5-三嗪-2,4,6-三酮(TBCA)。Preferably, the bromination reagent is N-bromosuccinimide (NBS), 1,3-dibromo-5,5-dimethylhydantoin (DBH), 3,5-dibromobenzaldehyde (DBBA), N-bromophthalimide (NBP) or 1,3,5-tribromo-1,3,5-triazine-2,4,6-trione (TBCA).
优选地,所述方法包括将溴化试剂(优选NBS)或者溴化试剂和有机溶剂的体系(优选NBS和N,N-二甲基甲酰胺的体系)滴加到化合物11和有机溶剂(优选N,N-二甲基甲酰胺)的体系中,滴加结束后升温反应。Preferably, the method comprises adding a bromination reagent (preferably NBS) or a system of a bromination reagent and an organic solvent (preferably a system of NBS and N,N-dimethylformamide) to compound 11 and an organic solvent (preferably N,N-dimethylformamide) system, after the dropwise addition, the temperature rises to react.
优选地,滴加过程中控制体系温度;更优选地,所述体系温度为-5~5℃,进一步优选0℃(例如冰浴)。Preferably, the temperature of the system is controlled during the dropwise addition; more preferably, the temperature of the system is -5-5°C, further preferably 0°C (for example, an ice bath).
优选地,所述方法还包括后处理的步骤,所述后处理的步骤包括:向反应体系中加入淬灭剂的水溶液和有机相溶剂,萃取,浓缩有机相,即得。优选地,所述淬灭剂为亚硫酸氢盐,优选亚硫酸氢钠;所述有机相溶剂为酯,优选乙酸乙酯。Preferably, the method further includes a post-treatment step, and the post-treatment step includes: adding an aqueous solution of a quencher and an organic phase solvent to the reaction system, extracting, and concentrating the organic phase to obtain the product. Preferably, the quenching agent is bisulfite, preferably sodium bisulfite; the organic phase solvent is ester, preferably ethyl acetate.
而在CN103608333B中,该步反应的滴加过程并未控温,在室温下进行,该步反应的最终收率只有75%。并且,其后处理步骤是加入乙醚进行稀释,再用盐水进行洗涤,并未淬灭多余的NBS,若不纯化化合物12而直接进行氰基化反应,则多余的NBS可能会残留到氰基化反应中影响收率。However, in CN103608333B, the dropping process of this step reaction is not temperature-controlled, and is carried out at room temperature, and the final yield of this step reaction is only 75%. Moreover, the post-treatment step is to add diethyl ether for dilution, and then wash with brine, which does not quench the excess NBS. If the cyanation reaction is carried out directly without purifying compound 12, the excess NBS may remain in the cyanation reaction. affect the yield in the reaction.
进一步地,所述制备化合物15的方法的具体步骤为:Further, the specific steps of the method for preparing compound 15 are:
向反应瓶中加入N,N-二甲基甲酰胺、化合物11,搅拌溶解,冰浴条件下滴加NBS的N,N-二甲基甲酰胺溶液,滴加结束后自然升温至室温反应;反应结束后滴加亚硫酸氢钠水溶液,乙酸乙酯萃取,收集有机相,减压浓缩,得化合物12;Add N,N-dimethylformamide and compound 11 to the reaction flask, stir to dissolve, add NBS N,N-dimethylformamide solution dropwise under ice bath conditions, and naturally warm up to room temperature after the addition; After the reaction was completed, an aqueous solution of sodium bisulfite was added dropwise, extracted with ethyl acetate, the organic phase was collected and concentrated under reduced pressure to obtain compound 12;
向反应瓶中加入CuCN、N,N-二甲基甲酰胺,搅拌,将上述步骤所得化合物12滴加到反应瓶中,控制体系温度和滴加时间,滴加结束后升温反应;反应结束后降温至室温,加入氨水溶液和二氯甲烷搅拌,萃取,收集二氯甲烷层,饱和食盐水洗涤二氯甲烷层,收集有机层,浓缩,得粗品,粗品采用正庚烷打浆得化合物15;Add CuCN and N,N-dimethylformamide to the reaction flask, stir, add the compound 12 obtained in the above steps into the reaction flask dropwise, control the temperature of the system and the time of dropping, and raise the temperature to react after the addition; Cool down to room temperature, add ammonia solution and dichloromethane, stir, extract, collect the dichloromethane layer, wash the dichloromethane layer with saturated brine, collect the organic layer, and concentrate to obtain a crude product, which is beaten with n-heptane to obtain compound 15;
优选地,上述具体步骤中的反应温度、反应时间、反应试剂的摩尔比等参数如前述制备化合物12和化合物15的方法中所限定。Preferably, the parameters such as reaction temperature, reaction time, and molar ratio of reagents in the above specific steps are as defined in the aforementioned methods for preparing compound 12 and compound 15.
根据本发明的第二个方面,本发明提供了一种制备式A所示化合物的方法,所述方法包括:化合物15与非硫光气试剂在溶剂或非溶剂下反应生成式A所示化合物,反应方程式为:According to the second aspect of the present invention, the present invention provides a method for preparing the compound represented by formula A, the method comprising: reacting compound 15 with a non-thiophosgene reagent in a solvent or a non-solvent to generate the compound represented by formula A , the reaction equation is:
优选地,所述化合物15可以由第一个方面中所述方法制备而成。Preferably, the compound 15 can be prepared by the method described in the first aspect.
优选地,所述非硫光气试剂为N,N'-硫羰基二咪唑、二硫化碳、N,N-二甲基硫代氨基甲酰氯或硫代氯甲酸苯酯中任意一种。Preferably, the non-thiophosgene reagent is any one of N,N'-thiocarbonyldiimidazole, carbon disulfide, N,N-dimethylthiocarbamoyl chloride or phenyl thiochloroformate.
根据本发明的第三个方面,本发明提供了另一种制备式A所示化合物的方法,所述方法包括化合物12在溶剂和氰基化试剂的存在下反应生成化合物15,化合物15与非硫光气试剂在溶剂或非溶剂下反应生成式A所示化合物,反应方程式如下:According to the third aspect of the present invention, the present invention provides another method for preparing the compound shown in formula A, said method comprising reacting compound 12 in the presence of a solvent and a cyanation reagent to generate compound 15, compound 15 and non- Thiophosgene reagent reacts under solvent or non-solvent to generate the compound shown in formula A, and the reaction equation is as follows:
优选地,所述化合物15可以由第一个方面中的方法制备而成。Preferably, the compound 15 can be prepared by the method in the first aspect.
优选地,所述非硫光气试剂是指N,N'-硫羰基二咪唑、二硫化碳、N,N-二甲基硫代氨基甲酰氯或硫代氯甲酸苯酯,反应方程式如下:Preferably, the non-thiophosgene reagent refers to N,N'-thiocarbonyldiimidazole, carbon disulfide, N,N-dimethylthiocarbamoyl chloride or phenylthiochloroformate, and the reaction equation is as follows:
另外,申请人在前期研究中发现,通过控制反应条件,化合物15与非硫光气试剂可以生成一种新的关环产物:式I所示化合物或式II所示化合物。所以,本发明还提供了化合物15在制备式I所示化合物或式II所示化合物中的用途,其中,所述化合物15由第一个方面中所述方法制备而成。In addition, the applicant found in the previous research that by controlling the reaction conditions, compound 15 and non-thiophosgene reagents can generate a new ring-closing product: the compound shown in formula I or the compound shown in formula II. Therefore, the present invention also provides the use of compound 15 in preparing the compound shown in formula I or the compound shown in formula II, wherein the compound 15 is prepared by the method described in the first aspect.
以化合物15为原料,以N,N'-硫羰基二咪唑为反应试剂,在有机碱和有机溶剂的反应体系下反应,生成式I所示化合物,反应方程式如下:Using compound 15 as a raw material and N,N'-thiocarbonyldiimidazole as a reagent, react in a reaction system of an organic base and an organic solvent to generate a compound shown in formula I. The reaction equation is as follows:
优选地,所述化合物15可以由第一个方面中所述方法制备而成。Preferably, the compound 15 can be prepared by the method described in the first aspect.
优选地,所述有机碱为含氮有机碱;优选地,所述含氮有机碱为N,N-二异丙基乙胺(DIPEA)、N,N-二异丙基苯胺、4-二甲氨基吡啶(DMAP)、二甲基吡啶、咪唑、三乙胺或吡啶中的任意一种或两种以上,优选三乙胺和/或DMAP。Preferably, the organic base is a nitrogen-containing organic base; preferably, the nitrogen-containing organic base is N,N-diisopropylethylamine (DIPEA), N,N-diisopropylaniline, 4-di Any one or more of methylaminopyridine (DMAP), lutidine, imidazole, triethylamine or pyridine, preferably triethylamine and/or DMAP.
优选地,所述有机溶剂为卤代烃、芳烃、C2-C6腈,优选甲苯和/或乙腈。Preferably, the organic solvent is halogenated hydrocarbon, aromatic hydrocarbon, C2-C6 nitrile, preferably toluene and/or acetonitrile.
优选地,所述N,N'-硫羰基二咪唑的摩尔量为化合物15的1-3倍,优选2倍。Preferably, the molar amount of N,N'-thiocarbonyldiimidazole is 1-3 times, preferably 2 times, that of compound 15.
优选地,所述有机碱的摩尔量为化合物15的0.1-5倍,优选3倍。Preferably, the molar amount of the organic base is 0.1-5 times, preferably 3 times, that of compound 15.
优选地,所述反应的温度为反应温度为0℃至沸点以下,优选40℃至沸点以下,例如50-90℃,50-80℃,60-70℃或80~90℃。Preferably, the reaction temperature is from 0°C to below the boiling point, preferably from 40°C to below the boiling point, such as 50-90°C, 50-80°C, 60-70°C or 80-90°C.
同样地,以化合物15为原料,以二硫化碳为反应试剂,在有机碱和有机溶剂的反应体系下反应,生成式II所示化合物,反应方程式如下:Similarly, compound 15 is used as a raw material, and carbon disulfide is used as a reagent to react under the reaction system of an organic base and an organic solvent to generate a compound shown in formula II, and the reaction equation is as follows:
优选地,所述化合物15可以由第一个方面中所述方法制备而成。Preferably, the compound 15 can be prepared by the method described in the first aspect.
优选地,所述有机碱为三乙胺、吡啶、N,N-二异丙基乙胺(DIPEA)、三乙烯二胺(DABCO)、1,5-二氮杂双环[4.3.0]壬-5-烯(DBN)、1,8-二偶氮杂双螺环[5.4.0]十一-7-烯(DBU),4-二甲氨基吡啶(DMAP)、N-甲基吗啉、四甲基乙二胺或其混合物,更优选三乙烯二胺。Preferably, the organic base is triethylamine, pyridine, N,N-diisopropylethylamine (DIPEA), triethylenediamine (DABCO), 1,5-diazabicyclo[4.3.0]nonane -5-ene (DBN), 1,8-diazobispiro[5.4.0]undec-7-ene (DBU), 4-dimethylaminopyridine (DMAP), N-methylmorpholine , tetramethylethylenediamine or a mixture thereof, more preferably triethylenediamine.
优选地,所述有机溶剂为烷基酮类,优选地所述烷基酮为丙酮、丁酮或甲基异丁基酮,优选丙酮。Preferably, the organic solvent is an alkyl ketone, preferably the alkyl ketone is acetone, butanone or methyl isobutyl ketone, preferably acetone.
优选地,所述二硫化碳与化合物15的摩尔比为1-3倍,例如1.2、1.5或2.0倍,更优选1.2倍。Preferably, the molar ratio of carbon disulfide to compound 15 is 1-3 times, such as 1.2, 1.5 or 2.0 times, more preferably 1.2 times.
优选地,所述有机碱与化合物15的摩尔比为0.1-1倍,更优选为0.2-0.8倍(例如0.2,0.4,0.6,0.8),进一步优选0.4-0.5倍。Preferably, the molar ratio of the organic base to compound 15 is 0.1-1 times, more preferably 0.2-0.8 times (eg 0.2, 0.4, 0.6, 0.8), further preferably 0.4-0.5 times.
上述式I所示化合物或式II所示化合物可作为式A所示化合物制备过程中产生的杂质,用于式A所示化合物目标产品的质量控制,监控目标产品中式I所示化合物或式II所示化合物的含量,评价目标产品的质量。所以,本发明还提供了上述式I所示化合物或式II所示化合物或其制备方法在式A所示化合物的产品质量控制中的应用。The compound shown in the above formula I or the compound shown in the formula II can be used as the impurity produced in the preparation process of the compound shown in the formula A for the quality control of the target product of the compound shown in the formula A, and monitor the compound shown in the formula I or the formula II in the target product The content of the indicated compounds was used to evaluate the quality of the target product. Therefore, the present invention also provides the application of the compound represented by the above formula I or the compound represented by the formula II or the preparation method thereof in the product quality control of the compound represented by the formula A.
根据本发明的第四个方面,本发明提供了另一种制备式A所示化合物的方法,所述方法包括如下步骤:According to a fourth aspect of the present invention, the present invention provides another method for preparing the compound shown in formula A, said method comprising the steps of:
其中,P为氨基保护基;Wherein, P is an amino protecting group;
1)化合物15在硫氰酸盐和氨基保护剂的存在下生成化合物15-1;1) compound 15 generates compound 15-1 in the presence of thiocyanate and amino protecting agent;
优选地,所述化合物15可以由第一个方面中所述方法制备而成;Preferably, the compound 15 can be prepared by the method described in the first aspect;
优选地,所述硫氰酸盐为硫氰酸铵、硫氰酸钠、硫氰酸钾、硫氰酸镁或硫氰酸锰中任意一种,优选硫氰酸铵;Preferably, the thiocyanate is any one of ammonium thiocyanate, sodium thiocyanate, potassium thiocyanate, magnesium thiocyanate or manganese thiocyanate, preferably ammonium thiocyanate;
优选地,所述氨基保护基为烷氧羰基、酰基或烷基中的任意一种;进一步地,所述氨基保护基中的烷氧羰基可以被取代基取代或未被取代,所述取代基可以为芳基、烯基或烷基硅基;所述氨基保护基中的烷基可以被取代基取代或未被取代,所述取代基可以为芳基或被烷氧基取代的芳基;更进一步地,所述烷氧羰基为苄氧羰基Cbz、叔丁氧羰基Boc、芴甲氧羰基Fmoc、烯丙氧羰基Alloc或三甲基硅乙氧羰基Teoc中任意一种;所述酰基为邻苯二甲酰基Pht,对甲苯磺酰基Tos,三氟乙酰基Tfa或苯甲酰基Bz中任意一种,优选为苯甲酰基Bz;所述烷基为三苯甲基Trt,2,4-二甲氧基苄基Dmb,对甲氧基苄基Pmb或苄基Bn中任意一种;Preferably, the amino-protecting group is any one of alkoxycarbonyl, acyl or alkyl; further, the alkoxycarbonyl in the amino-protecting group may be substituted or unsubstituted, and the substituent It can be an aryl group, an alkenyl group or an alkylsilyl group; the alkyl group in the amino protecting group can be substituted or unsubstituted by a substituent, and the substituent can be an aryl group or an aryl group substituted by an alkoxy group; Furthermore, the alkoxycarbonyl group is any one of benzyloxycarbonyl Cbz, tert-butoxycarbonyl Boc, fluorenylmethoxycarbonyl Fmoc, allyloxycarbonyl Alloc or trimethylsilylethoxycarbonyl Teoc; the acyl group is Any one of phthaloyl Pht, p-toluenesulfonyl Tos, trifluoroacetyl Tfa or benzoyl Bz, preferably benzoyl Bz; the alkyl group is trityl Trt, 2,4- Any one of dimethoxybenzyl Dmb, p-methoxybenzyl Pmb or benzyl Bn;
2)化合物15-1脱除氨基保护基,生成化合物15-2;2) Compound 15-1 removes the amino protecting group to generate compound 15-2;
本领域普通技术人员可以根据保护基的不同,采用不同的脱保护基体系;优选地,化合物15-1可以在碱和溶剂的体系中脱除氨基保护基;所述碱为无机碱,优选碱金属氢氧化物,更优选为氢氧化钠或氢氧化钾;所述溶剂为醇类溶剂,优选甲醇、乙醇或异丙醇等;Those skilled in the art can use different deprotecting group systems according to different protecting groups; preferably, compound 15-1 can remove the amino protecting group in a system of base and solvent; the base is an inorganic base, preferably a base Metal hydroxide, more preferably sodium hydroxide or potassium hydroxide; The solvent is an alcoholic solvent, preferably methanol, ethanol or isopropanol, etc.;
3)化合物15-2脱除氨气,生成式A化合物;3) Compound 15-2 removes ammonia to generate a compound of formula A;
可以在高沸点的有机溶剂中加热脱除氨气,例如在甲苯、二甲苯、氯化苯、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲基亚砜或N-甲基吡咯烷酮中脱除氨气;也可以在有机溶剂和水的混合体系中,添加酸式盐(硫酸氢钠、硫酸氢钾、亚硫酸氢钠、亚硫酸氢钾、磷酸二氢钠、磷酸二氢钾、草酸氢钠、草酸氢钾等中的一种或多种)催化反应进行脱除氨气。Ammonia can be removed by heating in high-boiling organic solvents, such as toluene, xylene, chlorinated benzene, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide or N-methylpyrrolidone to remove ammonia; it is also possible to add acid salts (sodium bisulfate, potassium bisulfate, sodium bisulfite, potassium bisulfite, dihydrogen phosphate in a mixed system of organic solvent and water) One or more of sodium, potassium dihydrogen phosphate, sodium hydrogen oxalate, potassium hydrogen oxalate, etc.) catalytic reaction to remove ammonia.
根据本发明的第五个方面,本发明提供了另一种制备式A所示化合物的方法,所述方法包括:化合物12在溶剂和氰基化试剂的存在下反应生成化合物15,化合物15通过第四个方面中所述的方法生成式A所示化合物,反应方程式如下:According to a fifth aspect of the present invention, the present invention provides another method for preparing the compound shown in formula A, the method comprising: reacting compound 12 in the presence of a solvent and a cyanation reagent to generate compound 15, and compound 15 is passed through The method described in the fourth aspect generates the compound shown in formula A, and the reaction equation is as follows:
其中,P为氨基保护基。Wherein, P is an amino protecting group.
优选地,所述化合物15可由第一个方面中的方法制备而成。Preferably, the compound 15 can be prepared by the method in the first aspect.
发明的效果The effect of the invention
与现有技术相比,本发明具有如下优点:Compared with prior art, the present invention has following advantage:
1)本发明以化合物12为原料,采用直接氰基化的方法,通过一步反应制备得到化合物15;革除了酰基保护基的保护,反应步骤减少,原子经济性大大提高;通过控制溴代和氰基化两步反应中的加料顺序、加料方式、加料温度、反应温度、后处理等条件,反应总收率可达80%,远远高于CN103608333B中的总收率(溴代、酰基保护、氰基化和脱保护四步反应总收率为45.9%);尤其是氰基化反应的后处理采用了氨水萃取洗涤和正庚烷热打浆的步骤,去除了大量杂质,在保证高收率的前提下,使产品纯度也得到了很大提升。1) The present invention uses compound 12 as a raw material, adopts a direct cyanation method, and prepares compound 15 through a one-step reaction; the protection of the acyl protecting group is removed, the reaction steps are reduced, and the atom economy is greatly improved; According to the conditions such as feeding order, feeding method, feeding temperature, reaction temperature and post-treatment in the two-step reaction of alkylation, the total yield of reaction can reach 80%, which is far higher than the total yield in CN103608333B (bromo, acyl protection, The total yield of cyanation and deprotection four-step reaction is 45.9%); especially the post-treatment of cyanation reaction has adopted the steps of ammonia water extraction washing and n-heptane thermal beating, which removes a large amount of impurities and ensures high yield Under the premise, the product purity has also been greatly improved.
2)本发明采用N,N'-硫羰基二咪唑、二硫化碳、N,N-二甲基硫代氨基甲酰氯、硫代氯甲酸苯酯或硫氰酸盐等试剂制备式A化合物,替代了硫光气,解决了硫光气环境污染大、不利于生产放大的缺陷。同时,本发明还提供了化合物15可与N,N'-硫羰基二咪唑或二硫化碳等试剂在特定的反应条件下生成的一种新的关环产物,该关环产物或其制备方法可应用于式A化合物产品的质量控制。2) The present invention uses reagents such as N,N'-thiocarbonyldiimidazole, carbon disulfide, N,N-dimethylthiocarbamoyl chloride, phenyl thiochloroformate or thiocyanate to prepare the compound of formula A, replacing Thiophosgene solves the disadvantages of thiophosgene that pollutes the environment and is not conducive to production scale-up. At the same time, the present invention also provides a new ring-closing product that compound 15 can form with reagents such as N,N'-thiocarbonyldiimidazole or carbon disulfide under specific reaction conditions. The ring-closing product or its preparation method can be applied to In the quality control of formula A compound product.
附图说明Description of drawings
图1为本发明实施例1制备的化合物的HPLC图谱。Figure 1 is the HPLC spectrum of the compound prepared in Example 1 of the present invention.
图2为本发明实施例2制备的化合物的LC-MS图谱。Figure 2 is the LC-MS spectrum of the compound prepared in Example 2 of the present invention.
图3为本发明实施例2制备的化合物的核磁共振氢谱图。Figure 3 is the H NMR spectrum of the compound prepared in Example 2 of the present invention.
图4为本发明实施例3制备的化合物的LC-MS图谱。Figure 4 is the LC-MS spectrum of the compound prepared in Example 3 of the present invention.
具体实施方式detailed description
本发明中的“式A化合物”、“式A所示化合物”或“式A所示异硫氰酸芳基酯化合物”均是指具有以下结构的化合物,其为普克鲁胺(Pruxelutamide)的中间体。"Compound of formula A", "compound shown in formula A" or "aryl isothiocyanate compound shown in formula A" in the present invention all refer to the compound with the following structure, which is Proxelutamide (Pruxelutamide) intermediates.
还可进一步通过实施例来理解本发明,然而,要理解的是,这些实施例不限制本发明。现在已知的或进一步开发的本发明的变化被认为落入本文中描述的和以下要求保护的本发明范围之内。The invention can be further understood by the examples, however, it is to be understood that these examples do not limit the invention. Variations of the invention now known or further developed are considered to fall within the scope of the invention described herein and claimed below.
化合物15的HPLC检测方法如下:The HPLC detection method of compound 15 is as follows:
色谱柱:C18,150×4.6mm;柱温:25℃;流速:1.0mL/min;进样量:5μL;Chromatographic column: C18, 150×4.6mm; column temperature: 25°C; flow rate: 1.0mL/min; injection volume: 5μL;
检测波长:220nm;Detection wavelength: 220nm;
流动相:二元流动相体系:流动相A为0.02V%乙酸水溶液;流动相B为乙腈;Mobile phase: binary mobile phase system: mobile phase A is 0.02V% acetic acid aqueous solution; mobile phase B is acetonitrile;
洗脱方式:梯度洗脱(梯度洗脱过程中,流动相A的最大体积百分比为90%,最小体积百分比为0%)。Elution mode: gradient elution (during gradient elution, the maximum volume percentage of mobile phase A is 90%, and the minimum volume percentage is 0%).
实施例1化合物15的制备The preparation of embodiment 1 compound 15
向反应瓶中加入有机溶剂N,N-二甲基甲酰胺60ml、式11化合物12g,搅拌溶解,冰浴条件下滴加NBS的N,N-二甲基甲酰胺溶液40ml(NBS为式11化合物摩尔量的1.05倍),滴加结束后自然升温至室温,反应16-24h;反应结束后滴加亚硫酸氢钠水溶液淬灭多余的NBS,乙酸乙酯萃取(3×60ml),收集有机相,减压浓缩,得油状物的化合物12。Add 60ml of the organic solvent N,N-dimethylformamide and 12g of the compound of formula 11 into the reaction flask, stir to dissolve, and add 40ml of NBS N,N-dimethylformamide solution dropwise under ice bath conditions (NBS is the formula 11 1.05 times the molar weight of the compound), naturally warmed up to room temperature after the dropwise addition, and reacted for 16-24h; after the reaction was finished, aqueous sodium bisulfite solution was added dropwise to quench excess NBS, extracted with ethyl acetate (3 × 60ml), and the organic phase, concentrated under reduced pressure to obtain compound 12 as an oil.
向反应瓶中加入CuCN(为式11化合物摩尔量的1.1倍)、N,N-二甲基甲酰胺50ml,搅拌,20-30℃下将上述步骤所得化合物12全部滴加到反应瓶中,控制滴加时间为1-2h,滴加结束后升温至120-130℃反应6-8h;反应结束后降温至室温,然后加入50ml氨水溶液和二氯甲烷搅拌萃取(60ml×2),收集二氯甲烷层,然后采用饱和食盐水洗涤二氯甲烷层,收集有机层,浓缩至无馏分蒸出,得粗品,粗品采用60ml正庚烷在40-50℃下搅拌打浆6-8h后,过滤,干燥,得10.8g化合物15(HPLC面积归一化法测定其纯度为99.5%,保留时间为8.39min,HPLC图谱见图1),收率为80.0%(以化合物11投料量计算,且化合物15纯度以100%计算)。Add CuCN (1.1 times the molar amount of the compound of formula 11) and 50ml of N,N-dimethylformamide into the reaction flask, stir, and drop all the compound 12 obtained in the above steps into the reaction flask at 20-30°C, Control the dropwise addition time for 1-2h. After the dropwise addition, raise the temperature to 120-130°C for 6-8h; Chloromethane layer, then wash the dichloromethane layer with saturated brine, collect the organic layer, concentrate until no distillate is evaporated to obtain a crude product, which is stirred and beaten with 60ml of n-heptane at 40-50°C for 6-8h, then filtered, Dry to obtain 10.8g of compound 15 (the HPLC area normalization method measures its purity to be 99.5%, and the retention time is 8.39min, and the HPLC collection is shown in Figure 1), and the yield is 80.0% (calculated based on the compound 11 charging amount, and the compound 15 Purity is calculated as 100%).
申请人前期未对后处理进行优化,后处理过程中加入二氯甲烷与水,萃取,浓缩,得到产物纯度仅为83.3%,收率与上述方法基本相同。所以,后处理采取氨水联合正庚烷打浆可显著提高产品纯度,且产品损失较少。The applicant did not optimize the post-treatment in the early stage. During the post-treatment process, dichloromethane and water were added, extracted and concentrated. The purity of the product obtained was only 83.3%, and the yield was basically the same as the above method. Therefore, post-treatment using ammonia water combined with n-heptane beating can significantly improve product purity with less product loss.
实施例2Example 2
向反应瓶中加入化合物15(1.0g,4.9mmol)、N,N'-硫羰基二咪唑(1.75g,9.8mmol)、甲苯10ml和三乙胺(1.49g,14.7mmol),搅拌溶解,升温至80℃下反应6h,取样TLC监测,反应完全,停止加热,降温至室温。Add compound 15 (1.0g, 4.9mmol), N,N'-thiocarbonyldiimidazole (1.75g, 9.8mmol), 10ml of toluene and triethylamine (1.49g, 14.7mmol) into the reaction flask, stir to dissolve, and raise the temperature Reaction at 80°C for 6h, sampling by TLC monitoring, the reaction was complete, stop heating, and cool down to room temperature.
旋蒸除甲苯,采用色谱柱纯化(PE:EA=2:1,Rf=0.2-0.3),得式I所示化合物(1.13g),收率73.4%。Toluene was removed by rotary evaporation, and column purification (PE:EA=2:1, R f =0.2-0.3) was used to obtain the compound represented by formula I (1.13g), with a yield of 73.4%.
LC-MS:m/z 295.05[M+1]+;LC-MS: m/z 295.05[M+1] + ;
1H NMR(400MHz,DMSO-d6):δ8.73(s,1H),8.41(d,J=8.4Hz,1H),8.30(d,J=8.4Hz,1H),8.12(s,1H),7.28(s,1H)。 1 H NMR (400MHz, DMSO-d6): δ8.73(s, 1H), 8.41(d, J=8.4Hz, 1H), 8.30(d, J=8.4Hz, 1H), 8.12(s, 1H) ,7.28(s,1H).
实施例3Example 3
向反应瓶中加入化合物15(2.0g,10mmol)、二硫化碳(0.91g,12mmol)、丙酮20ml和三乙烯二胺0.5ml(为化合物15摩尔量的0.45倍),搅拌溶解,升温至40-50℃下反应6-8h后,取样TLC监测,反应完全,停止加热,降温至室温。Add compound 15 (2.0g, 10mmol), carbon disulfide (0.91g, 12mmol), 20ml of acetone and 0.5ml of triethylenediamine (0.45 times the molar amount of compound 15) into the reaction flask, stir to dissolve, and heat up to 40-50 After reacting at ℃ for 6-8h, sampling TLC monitoring, the reaction is complete, stop heating, and cool down to room temperature.
旋蒸除丙酮,采用色谱柱纯化(PE:EA=2:1,Rf=0.2-0.3),得式II所示化合物。Acetone was removed by rotary evaporation, and column purification (PE:EA=2:1, R f =0.2-0.3) was used to obtain the compound represented by formula II.
LC-MS:m/z 258.92[M-1]-。LC-MS: m/z 258.92 [M-1] - .
实施例4Example 4
按如上方法制备式A化合物,其中P为苯甲酰基。具体步骤为:Compounds of formula A, wherein P is benzoyl, are prepared as above. The specific steps are:
1)化合物15在硫氰酸铵和苯甲酰氯的存在下反应,后处理得到化合物15-1;1) Compound 15 was reacted in the presence of ammonium thiocyanate and benzoyl chloride, and post-treated to obtain compound 15-1;
2)化合物15-1在以氢氧化钠为碱、甲醇作为溶剂的情况下脱除苯甲酰基,后处理得到化合物15-2;2) Compound 15-1 removes the benzoyl group with sodium hydroxide as the base and methanol as the solvent, followed by post-treatment to obtain Compound 15-2;
3)化合物15-2在氯苯的溶剂体系内加热脱除氨气,生成目标产物式A化合物。3) Compound 15-2 is heated in a solvent system of chlorobenzene to remove ammonia to generate the target compound of formula A.
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110763447 | 2021-07-06 | ||
CN2021107634474 | 2021-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115583898A true CN115583898A (en) | 2023-01-10 |
Family
ID=84772599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210791874.8A Pending CN115583898A (en) | 2021-07-06 | 2022-07-05 | A kind of preparation method of aryl isothiocyanate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115583898A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118496163A (en) * | 2024-05-08 | 2024-08-16 | 奥锐特药业股份有限公司 | A preparation method of enzalutamide and its intermediates |
CN118496163B (en) * | 2024-05-08 | 2025-02-25 | 奥锐特药业股份有限公司 | A preparation method of enzalutamide and its intermediates |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102482230A (en) * | 2009-09-10 | 2012-05-30 | 童友之 | Androgen receptor antagonists and uses thereof |
CN105308025A (en) * | 2013-05-20 | 2016-02-03 | 杜邦公司 | Solid forms of fungicidal pyrazoles |
WO2021133894A1 (en) * | 2019-12-23 | 2021-07-01 | Biogen Ma Inc. | Btk inhibitors |
-
2022
- 2022-07-05 CN CN202210791874.8A patent/CN115583898A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102482230A (en) * | 2009-09-10 | 2012-05-30 | 童友之 | Androgen receptor antagonists and uses thereof |
CN105308025A (en) * | 2013-05-20 | 2016-02-03 | 杜邦公司 | Solid forms of fungicidal pyrazoles |
WO2021133894A1 (en) * | 2019-12-23 | 2021-07-01 | Biogen Ma Inc. | Btk inhibitors |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118496163A (en) * | 2024-05-08 | 2024-08-16 | 奥锐特药业股份有限公司 | A preparation method of enzalutamide and its intermediates |
CN118496163B (en) * | 2024-05-08 | 2025-02-25 | 奥锐特药业股份有限公司 | A preparation method of enzalutamide and its intermediates |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2698245C (en) | Process and intermediates for preparing integrase inhibitors | |
KR101096499B1 (en) | Method of manufacturing telmisartan | |
TWI697495B (en) | Synthesis of copanlisib and its dihydrochloride salt | |
CN108383749B (en) | Synthetic method of apaluamide and intermediate thereof | |
JP2016065058A5 (en) | ||
CN113666909B (en) | Topiroxostat preparation method | |
TW201625633A (en) | Synthesis of COPANLISIB and its dihydrochloride salt | |
CN106699570A (en) | Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone | |
CN108623567A (en) | Ao Si replaces the preparation method of Buddhist nun | |
CN114751894A (en) | Preparation method of oral medicine for treating neocoronary pneumonia | |
CN115583898A (en) | A kind of preparation method of aryl isothiocyanate | |
IT201800005874A1 (en) | PROCESS FOR THE PREPARATION OF APALUTAMIDE | |
CN111377864A (en) | Lovatinib impurity and preparation method and application thereof | |
WO2014067237A1 (en) | Telmisartan preparation method and intermediate thereof | |
CN107021930B (en) | Synthesize 1H, 1`H-(2,2`- bisbenzimidazole) -5,5`- diamines method | |
WO2022206742A1 (en) | Method for synthesizing thiohydantoin derivative by means of one-step method | |
CN110615823B (en) | Preparation method of (2 'R) -2' -deoxidized-2 '-fluoro-2' -methyluridine | |
WO2018122724A1 (en) | Temozolomide process | |
CN113024412A (en) | Preparation method of 2,4, 6-trichlorobenzonitrile | |
CN110770231B (en) | Preparation method of tyrosine kinase inhibitor and intermediate thereof | |
RU2828349C1 (en) | METHOD OF PRODUCING DIHALOGEN DERIVATIVE OF 1,2,3,4-TETRAHYDROPYRIDO- OR PYRIDO[1,2-a]BENZIMIDAZOLE-6,9-DIONE | |
CN114249677B (en) | Riluzole intermediate compound and preparation method thereof | |
CN102911129A (en) | Method for preparing substituted tetrazole compound | |
CN113773235B (en) | Synthesis method of clorsulon | |
Jadhao et al. | Copper-mediated [3+ 2] oxidative cyclization of oxime acetate and its utility in the formal synthesis of fentiazac |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230110 |